Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 70 of 70 entries
Sorted by: Best Match Show Resources per page
Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?.

Alimentary pharmacology & therapeutics

Mozdiak E, Weldeselassie Y, McFarlane M, Tabuso M, Widlak MM, Dunlop A, Tsertsvadze A, Arasaradnam RP.
PMID: 31286552
Aliment Pharmacol Ther. 2019 Aug;50(4):348-372. doi: 10.1111/apt.15378. Epub 2019 Jul 08.

BACKGROUND: National UK data on colorectal cancer (CRC) stage at diagnosis is incomplete. Site-specific fast-track (2-week wait) cancer data are not collected directly by NHS England. Policy making based on these data alone can lead to inaccuracy.AIMS: To review...

Cite
Mozdiak E, Weldeselassie Y, McFarlane M, et al. Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?. Aliment Pharmacol Ther. 2019;50(4):348-372doi: 10.1111/apt.15378.
Mozdiak, E., Weldeselassie, Y., McFarlane, M., Tabuso, M., Widlak, M. M., Dunlop, A., Tsertsvadze, A., & Arasaradnam, R. P. (2019). Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?. Alimentary pharmacology & therapeutics, 50(4), 348-372. https://doi.org/10.1111/apt.15378
Mozdiak, Ella, et al. "Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?." Alimentary pharmacology & therapeutics vol. 50,4 (2019): 348-372. doi: https://doi.org/10.1111/apt.15378
Mozdiak E, Weldeselassie Y, McFarlane M, Tabuso M, Widlak MM, Dunlop A, Tsertsvadze A, Arasaradnam RP. Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?. Aliment Pharmacol Ther. 2019 Aug;50(4):348-372. doi: 10.1111/apt.15378. Epub 2019 Jul 08. PMID: 31286552.
Copy Download .nbib Format: NLM
Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice.

Surgical endoscopy

Zhang W, Zhai Y, Chai N, Linghu E, Lu Z, Li H, Feng X.
PMID: 29264756
Surg Endosc. 2018 Jun;32(6):2814-2821. doi: 10.1007/s00464-017-5986-y. Epub 2017 Dec 20.

BACKGROUND AND STUDY AIMS: ESTD and ESD are currently the two primary treatment options for superficial esophageal squamous cell neoplasm (SESCN) in China. However, in larger cases, ESD proves to be technically challenging and time saving, whereas ESTD exhibits...

Cite
Zhang W, Zhai Y, Chai N, et al. Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice. Surg Endosc. 2017;32(6):2814-2821doi: 10.1007/s00464-017-5986-y.
Zhang, W., Zhai, Y., Chai, N., Linghu, E., Lu, Z., Li, H., & Feng, X. (2018). Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice. Surgical endoscopy, 32(6), 2814-2821. https://doi.org/10.1007/s00464-017-5986-y
Zhang, Wengang, et al. "Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice." Surgical endoscopy vol. 32,6 (2018): 2814-2821. doi: https://doi.org/10.1007/s00464-017-5986-y
Zhang W, Zhai Y, Chai N, Linghu E, Lu Z, Li H, Feng X. Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice. Surg Endosc. 2018 Jun;32(6):2814-2821. doi: 10.1007/s00464-017-5986-y. Epub 2017 Dec 20. PMID: 29264756.
Copy Download .nbib Format: NLM
Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort.

The Permanente journal

Schneider JL, Feigelson HS, Quinn VP, McMullen C, Pawloski PA, Powers JD, Sterrett AT, Arterburn D, Corley DA.
PMID: 33183496
Perm J. 2020;24. doi: 10.7812/TPP/19.182.

INTRODUCTION: Colorectal cancer (CRC) incidence and mortality can be reduced by effective screening and/or treatment. However, the influence of health care systems on disparities among insured patients is largely unexplored.METHODS: To evaluate insured patients with CRC diagnosed between 2010...

Cite
Schneider JL, Feigelson HS, Quinn VP, et al. Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. Perm J. 2020;24doi: 10.7812/TPP/19.182.
Schneider, J. L., Feigelson, H. S., Quinn, V. P., McMullen, C., Pawloski, P. A., Powers, J. D., Sterrett, A. T., Arterburn, D., & Corley, D. A. (2020). Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. The Permanente journal, 24. https://doi.org/10.7812/TPP/19.182
Schneider, Jennifer L, et al. "Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort." The Permanente journal vol. 24 (2020). doi: https://doi.org/10.7812/TPP/19.182
Schneider JL, Feigelson HS, Quinn VP, McMullen C, Pawloski PA, Powers JD, Sterrett AT, Arterburn D, Corley DA. Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. Perm J. 2020;24. doi: 10.7812/TPP/19.182. PMID: 33183496; PMCID: PMC7417079.
Copy Download .nbib Format: NLM
Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort.

The Permanente journal

Schneider JL, Feigelson HS, Quinn VP, McMullen C, Pawloski PA, Powers JD, Sterrett AT, Arterburn D, Corley DA.
PMID: 33183496
Perm J. 2020;24. doi: 10.7812/TPP/19.182.

INTRODUCTION: Colorectal cancer (CRC) incidence and mortality can be reduced by effective screening and/or treatment. However, the influence of health care systems on disparities among insured patients is largely unexplored.METHODS: To evaluate insured patients with CRC diagnosed between 2010...

Cite
Schneider JL, Feigelson HS, Quinn VP, et al. Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. Perm J. 2020;24doi: 10.7812/TPP/19.182.
Schneider, J. L., Feigelson, H. S., Quinn, V. P., McMullen, C., Pawloski, P. A., Powers, J. D., Sterrett, A. T., Arterburn, D., & Corley, D. A. (2020). Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. The Permanente journal, 24. https://doi.org/10.7812/TPP/19.182
Schneider, Jennifer L, et al. "Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort." The Permanente journal vol. 24 (2020). doi: https://doi.org/10.7812/TPP/19.182
Schneider JL, Feigelson HS, Quinn VP, McMullen C, Pawloski PA, Powers JD, Sterrett AT, Arterburn D, Corley DA. Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. Perm J. 2020;24. doi: 10.7812/TPP/19.182. PMID: 33183496; PMCID: PMC7417079.
Copy Download .nbib Format: NLM
[THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER].

Harefuah

Kuten J, Kesler M, Even-Sapir E.
PMID: 34263574
Harefuah. 2021 Jul;160(7):455-461.

INTRODUCTION: Accurate evaluation of the extent of disease in patients with prostate cancer is of great importance in guiding suitable treatment at all disease stages. Conventional imaging modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), which...

Cite
Kuten J, Kesler M, Even-Sapir E. [THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER]. Harefuah. 2021;160(7):455-461
Kuten, J., Kesler, M., & Even-Sapir, E. (2021). [THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER]. Harefuah, 160(7), 455-461.
Kuten, Jonathan, et al. "[THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER]." Harefuah vol. 160,7 (2021): 455-461.
Kuten J, Kesler M, Even-Sapir E. [THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER]. Harefuah. 2021 Jul;160(7):455-461. Hebrew. PMID: 34263574.
Copy Download .nbib Format: NLM
A review of the AJCC melanoma staging system in the TNM classification (eighth edition).

Japanese journal of clinical oncology

Ogata D, Namikawa K, Takahashi A, Yamazaki N.
PMID: 33709104
Jpn J Clin Oncol. 2021 Apr 30;51(5):671-674. doi: 10.1093/jjco/hyab022.

In the eighth edition of the American Joint Committee on Cancer Staging Manual, several modifications were made for melanoma. These modifications were aimed at improving the prognosis prediction accuracy of the staging system. The main modifications are as follows:...

Cite
Ogata D, Namikawa K, Takahashi A, et al. A review of the AJCC melanoma staging system in the TNM classification (eighth edition). Jpn J Clin Oncol. 2021;51(5):671-674doi: 10.1093/jjco/hyab022.
Ogata, D., Namikawa, K., Takahashi, A., & Yamazaki, N. (2021). A review of the AJCC melanoma staging system in the TNM classification (eighth edition). Japanese journal of clinical oncology, 51(5), 671-674. https://doi.org/10.1093/jjco/hyab022
Ogata, Dai, et al. "A review of the AJCC melanoma staging system in the TNM classification (eighth edition)." Japanese journal of clinical oncology vol. 51,5 (2021): 671-674. doi: https://doi.org/10.1093/jjco/hyab022
Ogata D, Namikawa K, Takahashi A, Yamazaki N. A review of the AJCC melanoma staging system in the TNM classification (eighth edition). Jpn J Clin Oncol. 2021 Apr 30;51(5):671-674. doi: 10.1093/jjco/hyab022. PMID: 33709104.
Copy Download .nbib Format: NLM
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic.

British journal of cancer

Lee AJX, Purshouse K.
PMID: 33767417
Br J Cancer. 2021 May;124(11):1777-1784. doi: 10.1038/s41416-021-01324-x. Epub 2021 Mar 25.

The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt their practice in the aim of protecting patients. Early evidence from China indicated that patients with cancer, and particularly those who had recently received chemotherapy...

Cite
Lee AJX, Purshouse K. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. Br J Cancer. 2021;124(11):1777-1784doi: 10.1038/s41416-021-01324-x.
Lee, A. J. X., & Purshouse, K. (2021). COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. British journal of cancer, 124(11), 1777-1784. https://doi.org/10.1038/s41416-021-01324-x
Lee, Alvin J X, and Purshouse, Karin. "COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic." British journal of cancer vol. 124,11 (2021): 1777-1784. doi: https://doi.org/10.1038/s41416-021-01324-x
Lee AJX, Purshouse K. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. Br J Cancer. 2021 May;124(11):1777-1784. doi: 10.1038/s41416-021-01324-x. Epub 2021 Mar 25. PMID: 33767417; PMCID: PMC7992513.
Copy Download .nbib Format: NLM
Tools used in the diagnosis and staging of lung cancer: what's old and what's new?.

QJM : monthly journal of the Association of Physicians

Currie GP, Kennedy AM, Denison AR.
PMID: 19372092
QJM. 2009 Jul;102(7):443-8. doi: 10.1093/qjmed/hcp038. Epub 2009 Apr 15.

No abstract available.

Cite
Currie GP, Kennedy AM, Denison AR. Tools used in the diagnosis and staging of lung cancer: what's old and what's new?. QJM. 2009;102(7):443-8doi: 10.1093/qjmed/hcp038.
Currie, G. P., Kennedy, A. M., & Denison, A. R. (2009). Tools used in the diagnosis and staging of lung cancer: what's old and what's new?. QJM : monthly journal of the Association of Physicians, 102(7), 443-8. https://doi.org/10.1093/qjmed/hcp038
Currie, G P, et al. "Tools used in the diagnosis and staging of lung cancer: what's old and what's new?." QJM : monthly journal of the Association of Physicians vol. 102,7 (2009): 443-8. doi: https://doi.org/10.1093/qjmed/hcp038
Currie GP, Kennedy AM, Denison AR. Tools used in the diagnosis and staging of lung cancer: what's old and what's new?. QJM. 2009 Jul;102(7):443-8. doi: 10.1093/qjmed/hcp038. Epub 2009 Apr 15. PMID: 19372092.
Copy Download .nbib Format: NLM
Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer.

In vivo (Athens, Greece)

Stokstad T, Sørhaug S, Amundsen T, Grønberg BH.
PMID: 33910841
In Vivo. 2021 May-Jun;35(3):1595-1603. doi: 10.21873/invivo.12416.

BACKGROUND: Time-to-treatment is defined as a quality indicator for cancer care but is not well documented. We investigated whether meeting Norwegian timeframes of 35/42 days from referral until start of chemotherapy or surgery/radiotherapy for lung cancer was associated with...

Cite
Stokstad T, Sørhaug S, Amundsen T, et al. Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo. 2021;35(3):1595-1603doi: 10.21873/invivo.12416.
Stokstad, T., Sørhaug, S., Amundsen, T., & Grønberg, B. H. (2021). Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In vivo (Athens, Greece), 35(3), 1595-1603. https://doi.org/10.21873/invivo.12416
Stokstad, Trine, et al. "Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer." In vivo (Athens, Greece) vol. 35,3 (2021): 1595-1603. doi: https://doi.org/10.21873/invivo.12416
Stokstad T, Sørhaug S, Amundsen T, Grønberg BH. Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo. 2021 May-Jun;35(3):1595-1603. doi: 10.21873/invivo.12416. PMID: 33910841; PMCID: PMC8193294.
Copy Download .nbib Format: NLM
Staging lung cancer patients.

The Annals of thoracic surgery

Worman LW.
PMID: 7469584
Ann Thorac Surg. 1980 Dec;30(6):612-3. doi: 10.1016/s0003-4975(10)61744-4.

No abstract available.

Cite
Worman LW. Staging lung cancer patients. Ann Thorac Surg. 1980;30(6):612-3doi: 10.1016/s0003-4975(10)61744-4.
Worman, L. W. (1980). Staging lung cancer patients. The Annals of thoracic surgery, 30(6), 612-3. https://doi.org/10.1016/s0003-4975(10)61744-4
Worman, L W. "Staging lung cancer patients." The Annals of thoracic surgery vol. 30,6 (1980): 612-3. doi: https://doi.org/10.1016/s0003-4975(10)61744-4
Worman LW. Staging lung cancer patients. Ann Thorac Surg. 1980 Dec;30(6):612-3. doi: 10.1016/s0003-4975(10)61744-4. PMID: 7469584.
Copy Download .nbib Format: NLM
Showing 61 to 70 of 70 entries